Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in NRCS-A from neonatal sepsis and NEC.
Antimicrobial agents and chemotherapy
View this publicationAntimicrobial agents and chemotherapy
View this publicationInfection
View this publicationJournal of bacteriology
View this publicationJournal of natural products
View this publicationCell chemical biology
View this publicationJournal of the American Chemical Society
View this publicationRSC chemical biology
View this publicationRSC chemical biology
View this publicationScience translational medicine
View this publicationNature
View this publication